BR0109783A - Tratamento de doenças renais - Google Patents
Tratamento de doenças renaisInfo
- Publication number
- BR0109783A BR0109783A BR0109783-0A BR0109783A BR0109783A BR 0109783 A BR0109783 A BR 0109783A BR 0109783 A BR0109783 A BR 0109783A BR 0109783 A BR0109783 A BR 0109783A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- kidney disease
- amlodipine
- normotensive
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0008332.9A GB0008332D0 (en) | 2000-04-04 | 2000-04-04 | Treament |
PCT/IB2001/000518 WO2001074390A2 (fr) | 2000-04-04 | 2001-03-28 | Traitement de troubles renaux |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0109783A true BR0109783A (pt) | 2003-01-21 |
Family
ID=9889228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0109783-0A BR0109783A (pt) | 2000-04-04 | 2001-03-28 | Tratamento de doenças renais |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1284719A2 (fr) |
JP (1) | JP2003528927A (fr) |
AR (1) | AR027763A1 (fr) |
AU (1) | AU2001239510A1 (fr) |
BR (1) | BR0109783A (fr) |
CA (1) | CA2403950A1 (fr) |
GB (1) | GB0008332D0 (fr) |
MX (1) | MXPA02009819A (fr) |
PA (1) | PA8514601A1 (fr) |
PE (1) | PE20011163A1 (fr) |
TN (1) | TNSN01051A1 (fr) |
WO (1) | WO2001074390A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT5874U1 (de) * | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
AU2001294354A1 (en) * | 2000-12-29 | 2002-07-16 | Bioorganics B.V. | Process for making amlodipine, derivatives thereof, and precursors therefor |
US7335380B2 (en) | 2000-12-29 | 2008-02-26 | Synthon Ip Inc. | Amlodipine free base |
DK1443917T3 (da) * | 2001-11-07 | 2006-07-17 | Synthon Bv | Tamsulosintabletter |
NL1019882C2 (nl) * | 2002-02-01 | 2003-08-04 | Synthon Licensing | Amlodipine vrije base. |
CO5400144A1 (es) * | 2002-03-11 | 2004-05-31 | Novartis Ag | Compuestos organicos |
US7423009B2 (en) | 2002-09-30 | 2008-09-09 | Kowa Company, Ltd. | Method for treatment of kidney diseases |
AU2004208615C1 (en) | 2003-01-31 | 2010-05-13 | Daiichi Sankyo Company, Limited | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
US20080268049A1 (en) * | 2005-02-11 | 2008-10-30 | Dhaliwal Mona | Stable Solid Dosage Forms of Amlodipine and Benazepril |
MX2007011119A (es) | 2005-03-15 | 2007-11-14 | Lupin Ltd | Composiciones farmaceuticas de amlodipino y benazepril. |
EP1874131A2 (fr) * | 2005-04-29 | 2008-01-09 | Hill's Pet Nutrition Inc. | Methodes permettant de prolonger la vie des felins |
CA3015964C (fr) * | 2016-03-24 | 2021-08-03 | Daiichi Sankyo Company, Limited | Medicament pour le traitement d'une maladie renale |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8710493D0 (en) * | 1987-05-02 | 1987-06-03 | Pfizer Ltd | Dihydropyridines |
DE69105040T2 (de) * | 1990-05-31 | 1995-03-23 | Pfizer, Inc., New York, N.Y. | Arzneimittel gegen Impotenz. |
NZ242724A (en) * | 1991-05-15 | 1994-09-27 | Du Pont | Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker |
EP1262182A3 (fr) * | 1991-11-26 | 2003-02-26 | Sepracor Inc. | Procédés et compositions destinés à traiter l'hypertension, l'angine de poitrine et d'autres troubles à l'aide de (-) amlodipine optiquement pure |
WO1996028185A2 (fr) * | 1995-03-16 | 1996-09-19 | Pfizer Inc. | Composition contenant de l'amlopidine, ou un sel ou de la felodipine et un inhibiteur de l'enzyme de conversion de l'angiotensine |
EP0795327A1 (fr) * | 1996-03-13 | 1997-09-17 | Pfizer Inc. | Utilisation de l'amlodipine pour le traitement et la prophylaxie de l'insuffisance cardiaque congestive d'origine non-ischémique |
-
2000
- 2000-04-04 GB GBGB0008332.9A patent/GB0008332D0/en not_active Ceased
-
2001
- 2001-03-28 AU AU2001239510A patent/AU2001239510A1/en not_active Abandoned
- 2001-03-28 WO PCT/IB2001/000518 patent/WO2001074390A2/fr not_active Application Discontinuation
- 2001-03-28 EP EP01914134A patent/EP1284719A2/fr not_active Withdrawn
- 2001-03-28 MX MXPA02009819A patent/MXPA02009819A/es unknown
- 2001-03-28 JP JP2001572132A patent/JP2003528927A/ja not_active Abandoned
- 2001-03-28 CA CA002403950A patent/CA2403950A1/fr not_active Abandoned
- 2001-03-28 BR BR0109783-0A patent/BR0109783A/pt not_active IP Right Cessation
- 2001-04-02 PE PE2001000305A patent/PE20011163A1/es not_active Application Discontinuation
- 2001-04-03 TN TNTNSN01051A patent/TNSN01051A1/fr unknown
- 2001-04-03 PA PA20018514601A patent/PA8514601A1/es unknown
- 2001-04-03 AR ARP010101580A patent/AR027763A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2403950A1 (fr) | 2001-10-11 |
MXPA02009819A (es) | 2003-03-27 |
PA8514601A1 (es) | 2002-08-26 |
PE20011163A1 (es) | 2001-11-12 |
AU2001239510A1 (en) | 2001-10-15 |
EP1284719A2 (fr) | 2003-02-26 |
AR027763A1 (es) | 2003-04-09 |
TNSN01051A1 (fr) | 2005-11-10 |
WO2001074390A2 (fr) | 2001-10-11 |
JP2003528927A (ja) | 2003-09-30 |
GB0008332D0 (en) | 2000-05-24 |
WO2001074390A3 (fr) | 2002-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0109783A (pt) | Tratamento de doenças renais | |
FIU20060389U0 (fi) | Luusairauksien hoito | |
IS2782B (is) | Lyfja- og snyrtivörusamsetningar sem ná yfir þorskserínprótínasa og lyfja- og snyrtivörunotkun þeirra | |
BRPI0409791A (pt) | ligandos de receptores de canabinóides e sua utilização | |
DE69734483D1 (de) | Polynukleotid-Impfstoff, vorzugsweise zur Behandlung der Atemkrankheit bei Rindern | |
BRPI0409634A (pt) | ligantes de receptores de canabinóides e utilização destes | |
MA26545A1 (fr) | Procedes de cicatrisation des os | |
ID23496A (id) | Ekstrak tanaman untuk mengobati peningkatan resorpsi tulang | |
BR0113176A (pt) | Compostos biciclo-pirazol, composições farmacêuticas compreendendo os compostos, uso dos compostos na fabricação de medicamentos, processos para a preparação dos compostos, coleção quìmica combinatória e métodos para o tratamento de mamìferos incluindo humanos utilizando os compostos | |
ATE429922T1 (de) | Topische gel-abgabesysteme zur behandlung von hauterkrankungen | |
DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
DE60130008D1 (de) | Proteinkombinationen zur heilung von wunden | |
BR0209430B1 (pt) | compostos heterocíclicos, processo para sua preparação, composições para o combate de pragas animais, uso dos referidos compostos, bem como preparação das referidas composições | |
ATE246708T1 (de) | Elatase-inhibitoren | |
ID24060A (id) | Pengolahan kulit hewan yang ditingkatkan | |
DE69737029D1 (de) | Biomembran zur substitution, rekonstruktion, induktion der angiogenese, neubildung oder regeneration von menschlichen oder tierischen organen oder gewebe | |
DE69831223D1 (de) | Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52 | |
DE60105053D1 (de) | Zusammensetzungen zur behandlung von gewebe | |
DE60122601D1 (de) | Behandlung von entzündlichen Darmerkrankungen | |
MA25594A1 (fr) | Facteur stimulant d'os. | |
DE69704220T2 (de) | Synergistische fungizide Mischungen zur Bekämpfung von Pflanzenkrankheiten | |
BR9708648A (pt) | Muteina de il-6 | |
BR9509592A (pt) | Fluorobutenilésteres sua aplicação para o combate de pragas animais | |
UY26652A1 (es) | Tratamiento de trastornos renales | |
ATE285468T1 (de) | Gewebehandlungszubereitung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE 6A., 7A., E 8A. ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009. |